Insider Transactions in Q3 2022 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
5,765
-4.12%
|
$23,060
$4.25 P/Share
|
|
Sep 30
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,732
-0.98%
|
$30,928
$4.25 P/Share
|
|
Sep 30
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,282
-4.7%
|
$45,128
$4.25 P/Share
|
|
Sep 30
2022
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,445
-7.02%
|
$45,780
$4.25 P/Share
|
|
Sep 30
2022
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,211
-4.0%
|
$36,844
$4.25 P/Share
|
|
Sep 30
2022
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,154
-0.78%
|
$28,616
$4.25 P/Share
|
|
Sep 30
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,382
-3.84%
|
$21,528
$4.25 P/Share
|
|
Sep 30
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,003
-1.43%
|
$8,012
$4.07 P/Share
|
|
Sep 30
2022
|
David J Grainger Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
2,328
-0.25%
|
$9,312
$4.07 P/Share
|
|
Sep 30
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.67%
|
$16,000
$4.07 P/Share
|
|
Sep 30
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
2,468
-0.31%
|
$9,872
$4.07 P/Share
|
|
Sep 30
2022
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
3,725
-2.29%
|
$14,900
$4.07 P/Share
|
|
Sep 30
2022
|
Javad Shahidi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,727
-1.65%
|
$10,908
$4.07 P/Share
|
|
Sep 30
2022
|
David M Chao Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,401
-1.48%
|
$13,604
$4.07 P/Share
|
|
Sep 30
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
2,118
-1.51%
|
$8,472
$4.07 P/Share
|
|
Sep 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
10,423
-1.3%
|
$41,692
$4.41 P/Share
|
|
Aug 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
10,423
-1.29%
|
$41,692
$4.45 P/Share
|
|
Jul 18
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
20,000
-2.41%
|
$80,000
$4.87 P/Share
|
|
Jul 01
2022
|
Antoine Yver EVP & Chairman of Development |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+10.75%
|
-
|
|
Jul 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,100
-1.23%
|
$45,500
$5.03 P/Share
|
|
Jul 01
2022
|
Saurabh Saha Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+50.0%
|
-
|
|
Jul 01
2022
|
Gregory M Weinhoff Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+48.94%
|
-
|
|
Jul 01
2022
|
David J Grainger Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.86%
|
-
|
|
Jul 01
2022
|
Javad Shahidi Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
165,000
+50.0%
|
-
|
|
Jul 01
2022
|
Thomas Templeman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+49.96%
|
-
|
|
Jul 01
2022
|
Iqbal J Hussain General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+49.54%
|
-
|
|
Jul 01
2022
|
David M Chao Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+49.95%
|
-
|
|
Jul 01
2022
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|